Rigel Pharmaceuticals (NASDAQ: RIGL) kicked off on Friday, up 5.42% from the previous trading day, before settling in for the closing price of $43.84. Over the past 52 weeks, RIGL has traded in a range of $14.63-$47.26.
While this was happening, its average annual earnings per share was recorded 541.79%. With a float of $17.67 million, this company’s outstanding shares have now reached $18.14 million.
Rigel Pharmaceuticals (RIGL) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rigel Pharmaceuticals is 2.65%, while institutional ownership is 82.93%. The most recent insider transaction that took place on Feb 04 ’25, was worth 42,595. In this transaction EVP & Chief Financial Officer of this company sold 2,036 shares at a rate of $20.92, taking the stock ownership to the 58,969 shares. Before that another transaction happened on Feb 05 ’25, when Company’s EVP & Chief Financial Officer sold 1,734 for $21.93, making the entire transaction worth $38,020. This insider now owns 57,235 shares in total.
Rigel Pharmaceuticals (RIGL) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.8 earnings per share (EPS), higher than consensus estimate (set at 0.58) by 0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.77 per share during the current fiscal year.
Rigel Pharmaceuticals (NASDAQ: RIGL) Trading Performance Indicators
Take a look at Rigel Pharmaceuticals’s (RIGL) current performance indicators. Last quarter, stock had a quick ratio of 2.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.97. Likewise, its price to free cash flow for the trailing twelve months is 12.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.17, a number that is poised to hit 1.00 in the next quarter and is forecasted to reach 4.07 in one year’s time.
Technical Analysis of Rigel Pharmaceuticals (RIGL)
Analysing the last 5-days average volume posted by the [Rigel Pharmaceuticals, RIGL], we can find that recorded value of 0.76 million was better than the volume posted last year of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 74.72%.
During the past 100 days, Rigel Pharmaceuticals’s (RIGL) raw stochastic average was set at 96.38%, which indicates a significant increase from 94.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.17 in the past 14 days, which was higher than the 1.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.82, while its 200-day Moving Average is $25.40. Now, the first resistance to watch is $47.95. This is followed by the second major resistance level at $49.68. The third major resistance level sits at $52.15. If the price goes on to break the first support level at $43.75, it is likely to go to the next support level at $41.28. Now, if the price goes above the second support level, the third support stands at $39.55.
Rigel Pharmaceuticals (NASDAQ: RIGL) Key Stats
The company with the Market Capitalisation of 838.86 million has total of 18,151K Shares Outstanding. Its annual sales at the moment are 179,280 K in contrast with the sum of 17,490 K annual income. Company’s last quarter sales were recorded 69,460 K and last quarter income was 27,900 K.
